In November 2017, it was announced that six patients implanted with Johnson & Johnson’s Pinnacle hip implant will share in a $247 million payday from the pharmaceutical company fueled by its faulty device. The patients—plaintiffs who filed lawsuits against the device manufacturer—alleged that the metal-on-metal design of the implant caused tissue death and bone erosion, …. Read More
In February 2016, the FDA issued a final order that requires medical device companies to submit premarket approval (PMA) applications by May 18th for two types of metal-on-metal hip replacement devices, including one with a cemented pelvic component and another with an uncemented pelvic component. In a statement released on its website, the FDA indicated that …. Read More
More than 7,500 claims have been filed against Johnson & Johnson’s subsidiary DePuy Orthopaedics concerning its defective metal-on-metal Pinnacle hip replacement system. In one of the newest claims, Pinnacle recipient Michael Baker experienced severe pain and complications after receiving the faulty hip implant in 2002 and had the device removed 10 years later. The claim …. Read More
More than 1,400 injured hip replacement patients who were excluded from an earlier $2.5 billion settlement due to the date of their replacement surgery have been extended compensation under an additional DePuy Orthopaedics settlement. Now, DePuy will pay up to $350 million to patients who underwent a revision surgery to replace their ASR XL hip implant …. Read More
Revision Surgery & Claim Eligibility Video Transcript Some of our clients have been suffering pain and symptoms that are associated with the implantation of a metal-on-metal device. But, for various medical reasons, [they] have not been able to have a revision surgery or [they] have elected not to have revision surgery at this point. However, …. Read More
